Skip to main content
OpenTrials

Clinical trial condition

Mucinoses

Explore clinical trials studying Mucinoses. Study availability and eligibility vary by location and protocol.

240 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Mucinoses trial results

Completed

A Dose-optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease

NCT00144781

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +12 more
Locations
  • Hospital Infantil Joana de Gusmao Florianópolis, Santa Catarina, Brazil
  • Universidade Federal de Minas Gerais Belo Horizonte, Brazil
  • Hospital de Clinical de Porto Alegre Porto Alegre, Brazil
  • Universidade Federal de Sao Paulo São Paulo, Brazil
View Trial Details
Completed

A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Years Old

NCT00146757

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +12 more
Locations
  • Hôpital E. Herriot Lyon, France
  • Johannes Gutenberg Universität Kinderklinik, Mainz, Germany
  • Sophia Children's Hospital Rotterdam, Netherlands
  • Willink Biochemical Genetics Unit Royal Hospital for Children Manchester, United Kingdom
View Trial Details
Completed

Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients

NCT00146770

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +12 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • University of Rochester Rochester, New York, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View all 25 locations
View Trial Details
Completed

Safety and Efficacy of Hunterase

NCT01645189

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +17 more
Locations
  • Samsug Medical Center Seoul, South Korea
View Trial Details
Completed

A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)

NCT01275066

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +10 more
Locations
  • Oakland, California, United States
  • Wilmington, Delaware, United States
  • Washington D.C., District of Columbia, United States
  • Chicago, Illinois, United States
View all 28 locations
View Trial Details

Related conditions